Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype

A PI3Kα-selective inhibitor has recently been approved for use in breast tumors harboring mutations in PIK3CA, the gene encoding p110α. Preclinical studies have suggested that the PI3K/AKT/mTOR signaling pathway influences stemness, a dedifferentiation-related cellular phenotype associated with aggr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ralitsa R. Madsen, Emily C. Erickson, Oscar M. Rueda, Xavier Robin, Carlos Caldas, Alex Toker, Robert K. Semple, Bart Vanhaesebroeck
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
Accès en ligne:https://doaj.org/article/f2d3dd26e39c4ceca26dce8f4f8da04b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!